Iowa Specialty Hospital - Belmond was recently named one of the iVantage Top 100 Critical Access Hospitals (CAHs) in the United States.
“Iowa Specialty Hospital – Belmond is proud of the efforts of its providers and staff who have contributed to our hospital achieving this designation,” said Amy McDaniel, Belmond CEO.
Iowa Specialty Hospital - Belmond scored in the top 100 of Critical Access Hospitals on the iVantage Hospital Strength INDEX™. The INDEX is the industry’s most comprehensive rating of US acute care hospitals and the only one to include the country’s 1,300 CAHs. The results recognize that the Top 100 Critical Access Hospitals provide a safety net to communities across rural America – measuring them across 62 different performance metrics, including quality, outcomes, patient perspective, affordability, population risk, and efficiency. The list of the top 100 Critical Access Hospitals and more information about the study can be found at www.iVantageHealth.com.
“Rural healthcare deserves the same performance analysis as all provider performance. It plays a vital role for communities across America, serving nearly 80 million people. The services provided in rural America are similar to those needed in any major metropolitan area, yet the volumes and economic resources provide little economies of scale, making for little benefit from scale. These top 100 Critical Access Hospitals exhibit a focused concern for their community benefits and needs, regardless of scale, reimbursement, and people’s ability to pay,” said Michael Topchik, Senior Vice President of iVantage Health Analytics.
To learn more about Iowa Specialty Hospital – Belmond, including providers, services, and other awards, visit www.IowaSpecialtyHospital.com.
iVantage is a leading advisory and business analytic services company applying Accelerated Healthcare Transformation™ and the VantagePoints™ platform to drive sustained, evidence-based results. The company’s unique combination of technology, content, and expert advisory services accelerates decision making for the new healthcare.